Standard BioTools to host inaugural ‘Proteomics Roundtable’ series

Standard BioTools (LAB) announced the launch of its inaugural Proteomics Roundtable Series – a program of virtual events designed to spark conversation about the rapidly evolving field of proteomics. The series will spotlight thought leaders and industry experts discussing groundbreaking research, technological advancements and real-world applications of proteomics shaping the future of healthcare. The first session will be: Is More Really More? Evaluating the Case for High-Plex, High-Quality Proteomics: Friday, June 6, 2025 – 11:00 am ET. Stephen Williams, MD, PhD, Chief Medical Officer at Standard BioTools will host a panel featuring investigators from the 30-year, 500,000-participant EPIC cancer study. These researchers will explain how they found “black swan” insights into the development of major cancers from proteins previously unmeasurable across massive cohorts. Speakers for this session include: Elio Riboli, MD – Professor of Cancer Epidemiology, Imperial College London; Marc Gunter, PhD – Professor and Chair in Cancer Epidemiology and Prevention, Imperial College London; Karl Smith-Byrne, DPhil – Senior Molecular Epidemiologist, University of Oxford.